Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
Hundreds of thousands of Americans stand to soon lose their access to cheaper weight-loss drugs, with a federal crackdown on copycat versions threatening to disrupt treatment and raise costs. The Food and Drug Administration has ordered producers and sellers of the less expensive products to wind down operations in theContinue Reading